Ross N Gushi

Array ( [id] => 7491009 [patent_doc_number] => 20110237780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTI-INFLAMMATORY DAB' [patent_app_type] => utility [patent_app_number] => 13/008342 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7310 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237780.pdf [firstpage_image] =>[orig_patent_app_number] => 13008342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586382 [patent_doc_number] => 20110280892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/974953 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 64907 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280892.pdf [firstpage_image] =>[orig_patent_app_number] => 12974953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347793 [patent_doc_number] => 20120208718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/499672 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10918 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202399 [patent_doc_number] => 20110065185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS' [patent_app_type] => utility [patent_app_number] => 12/846625 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065185.pdf [firstpage_image] =>[orig_patent_app_number] => 12846625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268336 [patent_doc_number] => 20100298544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/797737 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 12792 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571928 [patent_doc_number] => 08338576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Antibodies specific for DKK-1 and their uses' [patent_app_type] => utility [patent_app_number] => 12/777806 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 56498 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326876 [patent_doc_number] => 20100197595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/758714 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4787 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197595.pdf [firstpage_image] =>[orig_patent_app_number] => 12758714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596491 [patent_doc_number] => 07982024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Antibodies to insulin-like growth factor I receptor' [patent_app_type] => utility [patent_app_number] => 12/756417 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 36375 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982024.pdf [firstpage_image] =>[orig_patent_app_number] => 12756417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340053 [patent_doc_number] => 20100247545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ANTIBODIES TO M-CSF' [patent_app_type] => utility [patent_app_number] => 12/748602 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37472 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247545.pdf [firstpage_image] =>[orig_patent_app_number] => 12748602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6503979 [patent_doc_number] => 20100260752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'OPSONIC AND PROTECTIVE ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA' [patent_app_type] => utility [patent_app_number] => 12/691908 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35471 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260752.pdf [firstpage_image] =>[orig_patent_app_number] => 12691908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629396 [patent_doc_number] => 08361465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 12/690033 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 37117 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12690033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633191 [patent_doc_number] => 20100173428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Protein Phosphorylation By Basophillic Serine/Threonine Kinases' [patent_app_type] => utility [patent_app_number] => 12/683835 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32017 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173428.pdf [firstpage_image] =>[orig_patent_app_number] => 12683835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560246 [patent_doc_number] => 20100272640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/684090 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16344 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272640.pdf [firstpage_image] =>[orig_patent_app_number] => 12684090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453268 [patent_doc_number] => 20100189649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'MONOCLONAL ANTIBODIES TO ACTIVATED ERBB FAMILY MEMBERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/651527 [patent_app_country] => US [patent_app_date] => 2010-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27874 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189649.pdf [firstpage_image] =>[orig_patent_app_number] => 12651527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510806 [patent_doc_number] => 20110256579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Method for Verifying and/or Identifying Hormonally Effective Substances' [patent_app_type] => utility [patent_app_number] => 13/141342 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15619 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256579.pdf [firstpage_image] =>[orig_patent_app_number] => 13141342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581864 [patent_doc_number] => 20100291111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 12/642687 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16696 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291111.pdf [firstpage_image] =>[orig_patent_app_number] => 12642687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214620 [patent_doc_number] => 08193316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'TACI-Fc fusion proteins, methods of making and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/638392 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193316.pdf [firstpage_image] =>[orig_patent_app_number] => 12638392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635067 [patent_doc_number] => 20100226854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'MHC Peptide Complexes and Uses Thereof in Infectious Diseases' [patent_app_type] => utility [patent_app_number] => 12/619039 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 225802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226854.pdf [firstpage_image] =>[orig_patent_app_number] => 12619039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685454 [patent_doc_number] => 20100120687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Modulating apoptosis' [patent_app_type] => utility [patent_app_number] => 12/617639 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17113 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120687.pdf [firstpage_image] =>[orig_patent_app_number] => 12617639 [rel_patent_id] =>[rel_patent_doc_number] =>)